PAVE syndrome could be fatal

Article

Presumed Air by Vitrectomy Embolisation (PAVE) could be a fatal syndrome, states a paper in the British Journal of Ophthalmology.

Presumed Air by Vitrectomy Embolisation (PAVE) could be a fatal syndrome, states a paper in the British Journal of Ophthalmology.

A study led by Dr Robert E. Morris, Helen Keller Foundation for Research and Education, Birmingham, Alabama, USA, included the analysis of three cases of suspected venous air embolism (VAE). The team investigated how air exits the eye through vortex veins after accidental suprachoroidal air infusion.

The group performed vitrectomy on four donor eyes. During air fluid exchange the unsutured cannulas were partially withdrawn and this produced choroidal detachments that imitated accidental suprachoroidal air infusion from a slipping cannula. A water bath was used to partially submerge eyes with and without clamping of the vortex vein stumps.

According to the findings, extensive choroidal detachment was created in all eyes and all patients with open vortex veins demonstrated rapid air extravasation/bubbling.

The results of the experiment support the recognition of PAVE and demonstrate that simple surgical precautions can prevent the potentially fatal vitrectomy complication.

Please click here to read the abstract.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.